ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing

William E. Braun; Kaleab Z. Abebe; Godela Brosnahan; Charity G. Patterson; Arlene B. Chapman; Peter C. Harris; Marie C. Hogan; Ronald D. Perrone; Vicente E. Torres; Dana C. Miskulin; Theodore I. Steinman; Franz T. Winklhofer; Frederic F. Rahbari-Oskoui; Peter G. Czarnecki; Kyongtae T. Bae; Jared J. Grantham; Michael F. Flessner; Robert W. Schrier

doi:10.1053/j.ajkd.2017.09.008

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing

William E. Braun, Kaleab Z. Abebe, Godela Brosnahan, Charity G. Patterson, Arlene B. Chapman, Peter C. Harris, Marie C. Hogan, Ronald D. Perrone, Vicente E. Torres, Dana C. Miskulin, Theodore I. Steinman, Franz T. Winklhofer, Frederic F. Rahbari-Oskoui, Peter G. Czarnecki, Kyongtae T. Bae, Jared J. Grantham, Michael F. Flessner, Robert W. Schrier

Nephrology and Hypertension

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	294-296
Number of pages	3
Journal	American Journal of Kidney Diseases
Volume	71
Issue number	2
DOIs	https://doi.org/10.1053/j.ajkd.2017.09.008
State	Published - Feb 2018

ASJC Scopus subject areas

Nephrology

Access to Document

10.1053/j.ajkd.2017.09.008

Cite this

Braun, W. E., Abebe, K. Z., Brosnahan, G., Patterson, C. G., Chapman, A. B., Harris, P. C., Hogan, M. C., Perrone, R. D., Torres, V. E., Miskulin, D. C., Steinman, T. I., Winklhofer, F. T., Rahbari-Oskoui, F. F., Czarnecki, P. G., Bae, K. T., Grantham, J. J., Flessner, M. F., & Schrier, R. W. (2018). ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing. American Journal of Kidney Diseases, 71(2), 294-296. https://doi.org/10.1053/j.ajkd.2017.09.008

Braun, WE, Abebe, KZ, Brosnahan, G, Patterson, CG, Chapman, AB, Harris, PC, Hogan, MC, Perrone, RD, Torres, VE, Miskulin, DC, Steinman, TI, Winklhofer, FT, Rahbari-Oskoui, FF, Czarnecki, PG, Bae, KT, Grantham, JJ, Flessner, MF & Schrier, RW 2018, 'ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing', American Journal of Kidney Diseases, vol. 71, no. 2, pp. 294-296. https://doi.org/10.1053/j.ajkd.2017.09.008

@article{bf250ae0dfcc469a896a1944dddcb7bd,

title = "ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing",

author = "Braun, {William E.} and Abebe, {Kaleab Z.} and Godela Brosnahan and Patterson, {Charity G.} and Chapman, {Arlene B.} and Harris, {Peter C.} and Hogan, {Marie C.} and Perrone, {Ronald D.} and Torres, {Vicente E.} and Miskulin, {Dana C.} and Steinman, {Theodore I.} and Winklhofer, {Franz T.} and Rahbari-Oskoui, {Frederic F.} and Czarnecki, {Peter G.} and Bae, {Kyongtae T.} and Grantham, {Jared J.} and Flessner, {Michael F.} and Schrier, {Robert W.}",

note = "Funding Information: Support: This work was supported by grants from NIDDK (DK62402 to RWS, DK62411 to RDP, DK62410 to VET, DK082230 to CGM, DK62408 to ABC, and DK62401 to Washington University in St. Louis [WUSTL]) and the National Center for Research Resources General Clinical Research Centers (RR000039 to Emory University, RR000585 to the Mayo Clinic, RR000054 to Tufts Medical Center, RR000051 to the University of Colorado, RR023940 to the University of Kansas Medical Center, and RR001032 to Beth Israel Deaconess Medical Center) and by National Center for Advancing Translational Sciences Clinical and Translational Science Awards (RR025008, TR000454 to Emory University; RR024150, TR00135 to the Mayo Clinic; RR025752, TR001064 to Tufts University; RR025780, TR001082 to the University of Colorado; RR025758, TR001102 to Beth Israel Deaconess Medical Center; RR033179, TR000001 to the University of Kansas Medical Center; RR024989, TR000439 to Cleveland Clinic), by funding from the Zell Family Foundation (to the University of Colorado), and by a grant from the PKD Foundation. Study drugs were donated by Boehringer Ingelheim Pharmaceuticals Inc (telmisartan and matched placebo) and Merck & Co Inc (lisinopril).",

year = "2018",

month = feb,

doi = "10.1053/j.ajkd.2017.09.008",

language = "English (US)",

volume = "71",

pages = "294--296",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing

AU - Braun, William E.

AU - Abebe, Kaleab Z.

AU - Brosnahan, Godela

AU - Patterson, Charity G.

AU - Chapman, Arlene B.

AU - Harris, Peter C.

AU - Hogan, Marie C.

AU - Perrone, Ronald D.

AU - Torres, Vicente E.

AU - Miskulin, Dana C.

AU - Steinman, Theodore I.

AU - Winklhofer, Franz T.

AU - Rahbari-Oskoui, Frederic F.

AU - Czarnecki, Peter G.

AU - Bae, Kyongtae T.

AU - Grantham, Jared J.

AU - Flessner, Michael F.

AU - Schrier, Robert W.

N1 - Funding Information: Support: This work was supported by grants from NIDDK (DK62402 to RWS, DK62411 to RDP, DK62410 to VET, DK082230 to CGM, DK62408 to ABC, and DK62401 to Washington University in St. Louis [WUSTL]) and the National Center for Research Resources General Clinical Research Centers (RR000039 to Emory University, RR000585 to the Mayo Clinic, RR000054 to Tufts Medical Center, RR000051 to the University of Colorado, RR023940 to the University of Kansas Medical Center, and RR001032 to Beth Israel Deaconess Medical Center) and by National Center for Advancing Translational Sciences Clinical and Translational Science Awards (RR025008, TR000454 to Emory University; RR024150, TR00135 to the Mayo Clinic; RR025752, TR001064 to Tufts University; RR025780, TR001082 to the University of Colorado; RR025758, TR001102 to Beth Israel Deaconess Medical Center; RR033179, TR000001 to the University of Kansas Medical Center; RR024989, TR000439 to Cleveland Clinic), by funding from the Zell Family Foundation (to the University of Colorado), and by a grant from the PKD Foundation. Study drugs were donated by Boehringer Ingelheim Pharmaceuticals Inc (telmisartan and matched placebo) and Merck & Co Inc (lisinopril).

PY - 2018/2

Y1 - 2018/2

UR - http://www.scopus.com/inward/record.url?scp=85035329155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035329155&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2017.09.008

DO - 10.1053/j.ajkd.2017.09.008

M3 - Letter

C2 - 29203126

AN - SCOPUS:85035329155

SN - 0272-6386

VL - 71

SP - 294

EP - 296

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 2

ER -

ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this